Skip to main content

Table 5 Base case and probabilistic sensitivity analysis results

From: Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in Singapore

Comparison

Costs, 2020 US$

Incremental costs

QALYs

Incremental QALYs

ICER (cost per QALY), 2020 US$

A.Base case

  TAVI

70,959

31,467

2.92

0.10

315,760

  SAVR

39,492

-

2.82

A.Probabilistic sensitivity analysis

  TAVI

70,997

31,541

2.92

0.10

319,241

  SAVR

39,456

-

2.82

-

-

  1. Abbreviations: ICER Incremental cost-effectiveness ratio, QALY Quality-adjusted life year, SAVR Surgical aortic valve replacement, TAVI Transcatheter aortic valve implantation